Gustavo A. Rosario Benitez

Array ( [id] => 4461507 [patent_doc_number] => 07879985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Antibodies against human NKG2D and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/605187 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 22 [patent_no_of_words] => 60399 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879985.pdf [firstpage_image] =>[orig_patent_app_number] => 12605187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293971 [patent_doc_number] => 08221752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Antibodies against human interleukin-13 and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/575896 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 53 [patent_no_of_words] => 41443 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12575896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639791 [patent_doc_number] => 20100036100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/573992 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8491 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036100.pdf [firstpage_image] =>[orig_patent_app_number] => 12573992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441485 [patent_doc_number] => 20100104569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'HUMANIZED ANTIBODIES TO INTERFERON ALPHA RECEPTOR-1 (IFNAR-1)' [patent_app_type] => utility [patent_app_number] => 12/569205 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20720 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104569.pdf [firstpage_image] =>[orig_patent_app_number] => 12569205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11795111 [patent_doc_number] => 09404916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Use of a protein kinase inhibitor to detect immune cells, such as T cells' [patent_app_type] => utility [patent_app_number] => 13/119795 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 11678 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6368036 [patent_doc_number] => 20100074899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/561202 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 72946 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074899.pdf [firstpage_image] =>[orig_patent_app_number] => 12561202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670328 [patent_doc_number] => 20110319597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'VARIANT DOMAIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/058422 [patent_app_country] => US [patent_app_date] => 2009-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17891 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467344 [patent_doc_number] => 20100040616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/537705 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30613 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040616.pdf [firstpage_image] =>[orig_patent_app_number] => 12537705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527162 [patent_doc_number] => 20100203590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'ANTIBODIES THAT BIND INTERLEUKIN-4 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/535648 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 40425 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203590.pdf [firstpage_image] =>[orig_patent_app_number] => 12535648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588652 [patent_doc_number] => 20100061987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/534217 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 51609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061987.pdf [firstpage_image] =>[orig_patent_app_number] => 12534217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220012 [patent_doc_number] => 20100055107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHODS FOR PREVENTING HEMATOLOGICAL MALIGNANCIES AND GRAFT VERSUS HOST DISEASE BY ANTI-CD3 PRECONDITIONING' [patent_app_type] => utility [patent_app_number] => 12/533898 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 17466 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055107.pdf [firstpage_image] =>[orig_patent_app_number] => 12533898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586384 [patent_doc_number] => 20110280894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'HER2/NEU SPECIFIC T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/056827 [patent_app_country] => US [patent_app_date] => 2009-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9637 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280894.pdf [firstpage_image] =>[orig_patent_app_number] => 13056827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305882 [patent_doc_number] => 08227417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants' [patent_app_type] => utility [patent_app_number] => 12/509088 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 11165 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12509088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485361 [patent_doc_number] => 20090275126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/504717 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17169 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275126.pdf [firstpage_image] =>[orig_patent_app_number] => 12504717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348506 [patent_doc_number] => 20100021460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Methods of Treating Autoimmune Diseases Using CD4 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/502953 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 52153 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021460.pdf [firstpage_image] =>[orig_patent_app_number] => 12502953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586358 [patent_doc_number] => 20110280868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS OF PREVENTING OR TREATING T CELL MALIGNANCIES BY ADMINISTERING ANTI-CD2 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/466852 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 54850 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280868.pdf [firstpage_image] =>[orig_patent_app_number] => 12466852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538492 [patent_doc_number] => 08314213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Human equivalent monoclonal antibodies engineered from nonhuman variable regions' [patent_app_type] => utility [patent_app_number] => 12/426785 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 16 [patent_no_of_words] => 20816 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12426785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10649407 [patent_doc_number] => 09365644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Anti-TNFα antibody' [patent_app_type] => utility [patent_app_number] => 12/425763 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11574 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12425763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484543 [patent_doc_number] => 07883707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Induction of antigen specific immunnologic tolerance' [patent_app_type] => utility [patent_app_number] => 12/412986 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 18502 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/883/07883707.pdf [firstpage_image] =>[orig_patent_app_number] => 12412986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467525 [patent_doc_number] => 20100040630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING BONE LOSS' [patent_app_type] => utility [patent_app_number] => 12/410321 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24916 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040630.pdf [firstpage_image] =>[orig_patent_app_number] => 12410321 [rel_patent_id] =>[rel_patent_doc_number] =>)